Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Williamson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Pathology|February 1, 1997
Large intestinal lymphocytic phlebitis and venulitis in chronic ulcerative colitisR M Williamson, N I Walker, J W Searle, et al.
Anaesthesia|April 17, 2008
Postoperative muscle weakness in a patient recently treated with infliximabA D Drummond, R M Williamson, M A Silverdale, et al.
Pancreas|July 1, 1993
Ethionine-induced atrophy of rat pancreas involves apoptosis of acinar cellsN I Walker, C M Winterford, R M Williamson, et al.
The Journal of Organic Chemistry|May 26, 2001
Stereocontrol of intramolecular Diels-Alder reactions: synthetic studies and transition structure modeling with c5-substituted 1,3,8-nonatrienes and nonadienynesC I Turner, R M Williamson, M N Paddon-Row, et al.
Journal of Medicinal Chemistry|May 26, 1995
Potent, orally active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino acid uptake system in Chinese hamster ovary cellsJ H Li, C F Bigge, R M Williamson, et al.
QJM : Monthly Journal of the Association of Physicians|October 12, 2015
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes StudyJ R Morling, J A Fallowfield, I N Guha, et al.
QJM : Monthly Journal of the Association of Physicians|December 14, 2011
Prevalence and markers of advanced liver disease in type 2 diabetesR M Williamson, J F Price, P C Hayes, et al.
Pharmaceutical Research|April 23, 1999
Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonistN Surendran, K M Covitz, H Han, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 2, 2014
Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetesS J Jenks, B R Conway, T J Hor, et al.
Clinical Radiology|February 25, 2011
The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopyR M Williamson, E Perry, S Glancy, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pathology|February 1, 1997
Large intestinal lymphocytic phlebitis and venulitis in chronic ulcerative colitisR M Williamson, N I Walker, J W Searle, et al.
Anaesthesia|April 17, 2008
Postoperative muscle weakness in a patient recently treated with infliximabA D Drummond, R M Williamson, M A Silverdale, et al.
Pancreas|July 1, 1993
Ethionine-induced atrophy of rat pancreas involves apoptosis of acinar cellsN I Walker, C M Winterford, R M Williamson, et al.
The Journal of Organic Chemistry|May 26, 2001
Stereocontrol of intramolecular Diels-Alder reactions: synthetic studies and transition structure modeling with c5-substituted 1,3,8-nonatrienes and nonadienynesC I Turner, R M Williamson, M N Paddon-Row, et al.
Journal of Medicinal Chemistry|May 26, 1995
Potent, orally active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino acid uptake system in Chinese hamster ovary cellsJ H Li, C F Bigge, R M Williamson, et al.
QJM : Monthly Journal of the Association of Physicians|October 12, 2015
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes StudyJ R Morling, J A Fallowfield, I N Guha, et al.
QJM : Monthly Journal of the Association of Physicians|December 14, 2011
Prevalence and markers of advanced liver disease in type 2 diabetesR M Williamson, J F Price, P C Hayes, et al.
Pharmaceutical Research|April 23, 1999
Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonistN Surendran, K M Covitz, H Han, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 2, 2014
Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetesS J Jenks, B R Conway, T J Hor, et al.
Clinical Radiology|February 25, 2011
The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopyR M Williamson, E Perry, S Glancy, et al.
Pageof 3